… Editor’s note (July 12, 2021): On July 8, 2021, the FDA updated prescribing information for Aduhelm (aducanumab). The drug … improves? Then do regular brain scans to see if amyloid comes back? This hasn’t been studied, so we don’t really …

… Parkinson's is a complex disease that looks different across all individuals … two people with Parkinson's disease (PD) have the same symptoms, progression or care regimen. The newly launched … developed in partnership with Matthew Stern, MD, a former president of the International Parkinson and Movement …

… journal Health Affairs gives the lyrically inclined in our community a chance to participate in both themes at once by sharing experiences … not just Parkinson’s, and must be written in English. Visit the Health Affairs blog for further submission …

… Drug Repositioning Congress - Washington, DC Isradipine. Pioglitazone. Droxidopa.  What do these drugs have in common? They are all approved for other indications and are … talk will describe the process by which MJFF has funded pre-clinical and clinical projects at critical junctures, …

… According to a report in today’s New York Times , the European Medicines Agency has recommended that gene therapy be approved for use in a rare … at MJFF. Gene therapy works by attempting to change the expression of a person’s genes. In PD, the approach primarily …

… Michael J. Fox Foundation for Parkinson’s Research (MJFF) today announced the launch of a new $2 million initiative to … the course of the project will be dependent upon successful completion of these milestones. Letters of intent are due by … by June 2006. For more information, scientists should visit the Foundation’s Web site, www.michaeljfox.org . …